Cargando…
An early biomarker and potential therapeutic target of RUNX 3 hypermethylation in breast cancer, a system review and meta-analysis
Runt-related transcription factor 3 (RUNX3) methylation plays an important role in the carcinogenesis of breast cancer (BC). However, the association between RUNX3 hypermethylation and significance of BC remains under investigation. The purpose of this study is to perform a meta-analysis and literat...
Autores principales: | Lu, De-guo, Ma, Ying-mei, Zhu, Ai-ju, Han, Yun-wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400655/ https://www.ncbi.nlm.nih.gov/pubmed/27825140 http://dx.doi.org/10.18632/oncotarget.13125 |
Ejemplares similares
-
The clinicopathological significance of RUNX3 hypermethylation and mRNA expression in human breast cancer, a meta-analysis
por: Song, Xiao-yun, et al.
Publicado: (2016) -
Downregulation of the RUNX3 Gene by Promoter Hypermethylation and Hemizygous Deletion in Breast Cancer
por: Hwang, Ki-Tae, et al.
Publicado: (2007) -
Aberrantly hypermethylated ARID1B is a novel biomarker and potential therapeutic target of colon adenocarcinoma
por: Baldi, Salem, et al.
Publicado: (2022) -
Clinical significance and association of RUNX3 hypermethylation frequency with colorectal cancer: a meta-analysis
por: Mu, Wei-Ping, et al.
Publicado: (2014) -
Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target
por: Hung, Chin-Sheng, et al.
Publicado: (2018)